Document:

Exhibit 10.2

 

Execution
Version

 

AMENDED AND RESTATED MUTUAL RELEASE
OF CLAIMS

 

This Amended and Restated
Mutual Release of Claims (this “Mutual Release”) is made as of March 31, 2019, amending and restating that certain
Mutual Release of Claims, made as of March 7, 2019 (the “Original Mutual Release”), by and among (i) Aceto Corporation,
a New York corporation (“Parent”), Rising Pharmaceuticals, Inc., a Delaware corporation (“Rising”),
Acetris Health, LLC, a Delaware limited liability company (“Purchaser I”), Rising Health, LLC, a Delaware limited
liability company (“Purchaser II” and together with Purchaser I, “Purchasers”; Purchasers,
together with Parent, the “DPO Obligors”; and the DPO Obligors together with Rising, the “Parent Parties”),
Aceto Agricultural Chemicals Corporation, a New York corporation (“Aceto Agricultural”), Aceto Realty LLC, a
New York limited liability company (“Aceto Realty”), PACK Pharmaceuticals, LLC, an Arizona limited liability
company (“PACK”), Arsynco, Inc., a New Jersey corporation (“Arsynco”) and Acci Realty Corp.,
a New York corporation (“Acci”); Purchasers, together with Parent, Rising, Aceto Agricultural, Aceto Realty,
PACK, Arsynco and Acci, the “Debtors”); and (ii) Shore Pharma LLC, a New Jersey limited liability company, Cedar
Pharma LLC (f/k/a Citron Pharma LLC), a New Jersey limited liability company, Aster Pharma LLC (f/k/a Lucid Pharma LLC), a New
Jersey limited liability company, Citgen Pharma Holding LLC, a New Jersey limited liability company, Gensource Pharma LLC, a Delaware
limited liability company, SS Pharma LLC, a New Jersey limited liability company, Pharma Reach LLC, a New Jersey limited liability
company, Citgen Realty LLC, a New Jersey limited liability company, Sudha Kavuru, an individual, Vimal Kavuru, in his capacity
as an individual and in his capacity as Agent for the Members and Sellers (“Kavuru”), and Subha Sri Thogarchedu,
an individual (each of the parties in this clause (ii), collectively, the “Released Sellers”; and the Released
Sellers collectively with the Parent Parties, the “Parties”, and each individually, a “Party”).

 

RECITALS

 

WHEREAS, certain of
the Parent Parties and certain of the Released Sellers are parties to a Product Purchase Agreement, dated as of November 2, 2016
(as amended, the “Product Purchase Agreement”; capitalized terms used but not defined in this Mutual Release
shall have the meanings given to such terms in the Product Purchase Agreement, unless otherwise specified), pursuant to which,
among other things, such Released Sellers, directly or indirectly, sold certain assets to Purchasers, and Purchasers assumed certain
related liabilities;

 

WHEREAS, certain of
the Parent Parties, certain of the Released Sellers and certain other parties are parties to the Signing Agreements and Ancillary
Agreements (collectively with the Product Purchase Agreement, the “Transaction Agreements”), pursuant to the
terms of the Product Purchase Agreement;

 

WHEREAS, on February
19, 2019, the Debtors commenced voluntary petitions for relief under Chapter 11 of Title 11 of the United States Code, 11
U.S.C. §§ 101, et seq. (the “Bankruptcy Code”), in the United States Bankruptcy Court for the District
of New Jersey (the “Bankruptcy Court”), where such bankruptcy cases are jointly administered under Case No.
19-13448 (the “Bankruptcy Cases”);

 

     

     

    

 

WHEREAS, on March 7,
2019, PACK, Rising and Purchasers (together with PACK and Rising, the “Rising Sellers”), Parent, and Shore Suven
Pharma, Inc., a Delaware corporation (the “Rising Buyer”), entered into an Asset Purchase Agreement (the “Original
Rising Purchase Agreement”), pursuant to which, among other things, the Rising Sellers agreed to sell certain assets
to the Rising Buyer, and the Rising Buyer agreed to assume certain liabilities of the Rising Sellers (Buyer’s consummation
of such transaction pursuant to the terms and conditions set forth in the Rising Purchase Agreement (as defined below) or otherwise
in connection with the bankruptcy auction process, and pursuant to Section 363 of the Bankruptcy Code, the “Closing”);

 

WHEREAS, on March 7,
2019, the Parent Parties and the Released Sellers entered into the Original Mutual Release, and now desire to amend and restate
the terms and provisions of the Original Mutual Release in its entirety to, among other things, impose additional limitations on
the recovery of the Deferred Payment Amount, in accordance with and subject to the terms and conditions of this Mutual Release;

 

WHEREAS, on the date
hereof, concurrently with the execution of this Mutual Release, the Rising Sellers, Parent and the Rising Buyer have entered into
an Amended and Restated Asset Purchase Agreement (the “Rising Purchase Agreement”), pursuant to which the parties
thereto agreed to amend and restate the terms and provisions of the Original Rising Purchase Agreement in its entirety in accordance
with and subject to the terms and conditions of the Rising Purchase Agreement;

 

WHEREAS, in addition
to the mutual releases contained herein, as consideration for (a) the Rising Buyer’s agreement that the Rising Purchase Agreement
serve as a “stalking horse” in connection with a sale pursuant to Section 363 of the Bankruptcy Code, (b) an upfront
reduction of the Deferred Payment Amount, and the interest due thereon (subject to Section 3), in the amount of $18,500,000
by the Released Sellers, which will be accounted for by way of (i) a $500,000 reduction of the past due interest owed on the Deferred
Payment Amount (the “Interest Credit”) and (ii) a $18,000,000 reduction of the Deferred Payment Amount (the
“Release-Related DPA Reduction”), and (c) a full release of certain claims against each of the Debtors as set
forth in this Mutual Release, (1) the Rising Sellers will provide the Break-Up Fee and Expense Reimbursement to the Rising Buyer
in accordance with the terms described in the Rising Purchase Agreement and (2) the Debtors will provide a full release of certain
claims against the Released Sellers as set forth in this Mutual Release;

 

WHEREAS, the Parties
have also agreed to certain limitations on the treatment of the Deferred Payment Amount, including any interest thereon (the “DPO
Claims”);

 

WHEREAS, the Released
Sellers that are party to the Product Purchase Agreement were, or are presently, affiliated with the Rising Buyer, and the Purchasers
under the Product Purchase Agreement were, and are presently, affiliates of Rising and Parent;

 

WHEREAS, the Rising
Sellers and certain of the Released Sellers are in discussions regarding certain disputes and/or potential disputes in respect
of each of such Parties’ rights and obligations under the Product Purchase Agreement; and

 

    	 	-2-	 

     

    

 

WHEREAS, the Parties
wish to enter into this Mutual Release, to assure that, except as provided herein, all claims, demands, liabilities, damages, obligations,
actions, or causes of action of any kind between the Parties are fully and finally discharged, released, and resolved, without
any admission of wrongdoing, guilt, liability, obligation or otherwise.

 

NOW, THEREFORE, in
consideration of the foregoing and the representations, warranties, covenants and agreements contained herein, and for other good
and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound, the
Parties hereby agree to amend and restate the Original Mutual Release in its entirety to provide as follows:

 

		1.	Mutual Release.

 

		a.	Effective as of the Effective Date and only if the Effective Date occurs, and to the fullest extent
permitted by Law, each of the Debtors, on behalf of itself, its respective bankruptcy estate (including as may be asserted by the
Official Committee of Unsecured Creditors appointed in the Bankruptcy Cases) and any Person or entity claiming by, through or under
it, including their respective subsidiaries, affiliates, predecessors, successors, and assigns, and all of their respective directors,
managers, officers, agents, advisors, and representatives (collectively with all other such entities heretofore stated, the “Parent
Releasing Parties”) hereby irrevocably and unconditionally releases and forever discharges each Released Seller, including
their respective subsidiaries, affiliates, predecessors, successors, and assigns, and each of its respective past, present, and
future officers, directors, security holders, partners, agents, representatives, employees, advisors, attorneys, and all Persons
acting by, through, for, under, or in concert with any of the foregoing (collectively, the “Released Seller Parties”),
from any and all Proceedings, damages, costs, expenses, demands, debts, liabilities and obligations, whether known or unknown,
primary or secondary, direct or indirect, and whether or not accrued (“Claims”), which any Parent Releasing
Party now has or ever had from the beginning of time up to and including the Effective Date against any of the Released Seller
Parties, arising from any acts or omissions, state of facts or circumstances, or events which occurred, existed or were suffered
to exist from the beginning of time through and including the Effective Date, in each case, other than: (i) all rights and obligations
of the Rising Buyer under the Rising Purchase Agreement or any Ancillary Document (as defined in the Rising Purchase Agreement);
(ii) Claims arising from any criminal or administrative Proceeding brought by or in the right of any Governmental Authority, including,
without limitation, any violation, or alleged violation, of Competition Laws (except for the “TAA Matter” as defined
in the indemnification notices sent by one or more Parent Parties pursuant to the Product Purchase Agreement, which TAA Matter
shall be a Parent Released Claim that is released by this Mutual Release); and (iii) this Mutual Release (collectively, the “Parent
Released Claims”). Notwithstanding the foregoing, nothing in this paragraph shall inhibit the Parent Parties from asserting
any defenses or set-off rights to claims asserted by the Released Seller Parties (for the avoidance of doubt, excluding any claims
arising from any breach or failure to perform under the Rising Purchase Agreement or any Ancillary Documents) only with respect
to Claims released hereunder, which defenses and set-off rights are expressly preserved.

 

    	 	-3-	 

     

    

 

		b.	Each Parent Party hereby irrevocably covenants, from and after the Effective Date, to refrain from
asserting any claim or demand, or commencing, instituting or causing to be commenced, any Proceeding against any of the Released
Seller Parties based upon, arising from or relating to any Parent Released Claim or any Claim described in Section 1.a(ii),
subject only to the terms of this Mutual Release.

 

		c.	Effective as of the Effective Date and only if the Effective Date occurs, each of the Released
Seller Parties (collectively, the “Releasing Seller Parties”) hereby irrevocably and unconditionally releases
and forever discharges each of the Debtors, on behalf of itself and any Person or entity claiming by, through or under it, including
their respective subsidiaries, affiliates, predecessors, successors, and assigns, and all of their respective directors, managers,
officers, agents, advisors, and representatives (collectively, the “Released Parent Parties”), from any and
all Claims, which any Releasing Seller Parties now has or ever had from the beginning of time up to and including the Effective
Date against any of the Released Parent Parties, arising from any acts or omissions, state of facts or circumstances, or events
which occurred, existed or were suffered to exist from the beginning of time through and including the Effective Date, in each
case, other than: (i) all rights and obligations of each Released Seller Party under the Rising Purchase Agreement or any Ancillary
Document (as defined in the Rising Purchase Agreement) to which they are a party; (ii) subject to and as limited by Section
3 (it being understood that in the event of any conflict between this clause (ii) and Section 3, Section 3 shall
govern), all rights and obligations of a Parent Party for payment to any Released Seller in respect of (A) the Deferred Payment
Amount (less the Release-Related DPA Reduction and, if credited towards Purchase Price (as defined in the Rising Purchase Agreement)
upon Closing (as defined in the Rising Purchase Agreement), less the Deferred Payment Reduction (as defined in the Rising Purchase
Agreement)), (B) interest in respect of the Deferred Payment Amount (less the Interest Credit and, if credited towards Purchase
Price (as defined in the Rising Purchase Agreement) upon Closing (as defined in the Rising Purchase Agreement), less the amount
of the Seller Credit (as defined in the Rising Purchase Agreement) allocable to such interest payment) and (C) the payment due
under the Administration Services Agreement (unless credited towards Purchase Price (as defined in the Rising Purchase Agreement)
upon Closing (as defined in the Rising Purchase Agreement) as a portion of the amount of the Seller Credit (as defined in the Rising
Purchase Agreement) allocable to such payment); (iii) in the case of Kavuru, any rights and obligations of each Parent Party to
provide coverage and indemnification to Kavuru pursuant to any director and officer insurance or indemnification obligations in
respect of his position as a director or an officer of any Parent Party, in each case, as in effect on the date hereof; and (iv)
this Mutual Release (collectively, the “Seller Released Claims”). Notwithstanding the foregoing, nothing in
this paragraph shall inhibit the Released Sellers from asserting any defenses or set-off rights to claims asserted by the Released
Parent Parties (for the avoidance of doubt, excluding any claims arising from any breach or failure to perform under the Rising
Purchase Agreement or any Ancillary Documents) only with respect to Claims released hereunder, which defenses and set-off rights
are expressly preserved.

 

    	 	-4-	 

     

    

 

		d.	Each Released Seller hereby irrevocably covenants, from and after the Effective Date, to refrain
from asserting any claim or demand, or commencing, instituting or causing to be commenced, any Proceeding against any of the Released
Parent Parties based upon, arising from or relating to any Seller Released Claims.

 

		e.	Notwithstanding anything in this Mutual Release to the contrary, if any Released Seller Party or
Released Parent Party is found by a court of competent jurisdiction in a final non-appealable order to have breached this Mutual
Release, then this Mutual Release shall thereupon, without further action, notice or deed, be void ab initio with respect
to such Released Seller Party or Released Parent Party.

 

		f.	The “Effective Date” shall mean the later of (x) the date on which the Bankruptcy
Court approves this Mutual Release by Final Order (as defined in the Rising Purchase Agreement) and (y) the earliest of: (i) the
Closing (as defined in the Rising Purchase Agreement); (ii) consummation of an Alternative Transaction (as defined in the Rising
Purchase Agreement) in accordance with Section 8.1(h) of the Rising Purchase Agreement; or (iii) if (A) all of the conditions set
forth in Sections 7.1 and 7.2 of the Rising Purchase Agreement to the Rising Sellers’ obligations thereunder are satisfied
(other than those conditions that by their nature are to be satisfied at such Closing, provided, that such conditions would
have been satisfied assuming such Closing were to occur), (B) the Rising Buyer has irrevocably confirmed in writing to the Rising
Sellers that (1) all of the conditions set forth in Sections 7.1 and 7.3 of the Rising Purchase Agreement to the Rising Buyer’s
obligations thereunder have been satisfied or waived (other than those conditions that by their nature are to be satisfied or waived
at such Closing, provided, that such conditions would have been satisfied or waived assuming such Closing were to occur),
and (2) it is ready, willing and able to take the actions within its control to consummate such Closing in accordance with the
Rising Purchase Agreement, without further condition, and (C) the Rising Sellers fail to consummate such Closing, on the terms
and subject to the conditions set forth in the Rising Purchase Agreement, within three (3) Business Days following receipt of the
written confirmation by the Rising Buyer required by clause (iii)(B) of this Section 1.f. If the Rising Purchase Agreement
shall have terminated in accordance with its terms before the occurrence of the Effective Date or any of the Rising Sellers shall
have commenced an action for specific performance pursuant to Article VIII of the Rising Purchase Agreement, then this Mutual Release
shall, thereon, without further action, notice or deed, terminate and be void ab initio.

 

		g.	General Release. Subject only to the terms of this Mutual Release, the Parties and each
of them, agree to and hereby does release and discharge the Parent Released Parties and the Seller Released Parties (as the case
may be) from the Claims in Section 1.a and Section 1.c, which are based on acts or omissions occurring up to and
including the Effective Date.  The Parties understand and expressly agree that all rights under Section 1542 of the California
Civil Code, if any, are hereby expressly waived. That Section reads as follows:

 

    	 	-5-	 

     

    

 

“A general release does
not extend to claims that the creditor or releasing party does not know or suspect to exist in his or her favor at the time of
executing the release and that, if known by him or her, would have materially affected his or her settlement with the debtor or
released party.”

 

The waiver of Section 1542 provided
by this Section 1.g is an essential term of this Mutual Release without which the settlement would not have been reached.

 

		2.	Disclaimer of Reliance. In executing the releases set forth in Section 1 above, the
Parties intend this instrument to be effective as a full and final accord and satisfaction of the Parent Released Claims and the
Seller Released Claims. Each Party expressly warrants and represents that no promise or agreement that is not expressed in this
Mutual Release has been made to such Party as an inducement to execute this Mutual Release and each Party expressly disclaims reliance
upon any statement or representation of any Person or entity released hereby other than those expressly stated in this Mutual Release.
In entering into this Mutual Release, the Parties each expressly disclaim and waive any reliance on any written or oral representations,
other than those expressly stated herein.

 

		3.	DPO Claims. Any right to recovery or distribution of proceeds of or to any of the Released
Sellers with respect to or on account of the DPO Claims, whether under any plan confirmed in connection with the Bankruptcy Cases
or otherwise, shall be subject to, limited by and in accordance with this Section 3. “Intercompany Claims”
as used herein means any claim by any Debtor or any affiliate thereof (including any Debtor or non-Debtor affiliate) against any
other Debtor. The DPO Claims shall be allowed in an aggregate amount equal to and not more than $30,000,000 against each respective
DPO Obligor’s bankruptcy estate. The holder(s) of the DPO Claims shall receive, with respect to the DPO Claims, such distributions
solely from the respective DPO Obligor’s bankruptcy estates on a pro rata basis (based on allowed DPO Claims in the
amount of $30,000,000) together with the allowed claims of all other general unsecured creditors of the respective DPO Obligors
participating in such distributions until such holder(s) of the DPO Claims have received, in the aggregate, their pro rata
distribution in an amount up to, but not exceeding, $6,500,000 (the “Initial Recovery Amount”). From and after
the time when the holder(s) of the DPO Claims have received, in the aggregate, the Initial Recovery Amount, the DPO Claims shall
be subordinated to the allowed claims of all other general unsecured creditors of the Debtors’ collective bankruptcy estates
and the holder(s) of the DPO Claims shall not receive any additional recovery thereon, under a confirmed plan or otherwise, until
all such other holders of general unsecured claims collectively in the bankruptcy estates of the Debtors (treated as if all estates
are substantively consolidated, whether substantive consolidation is sought or approved and without giving effect to Intercompany
Claims) have received a recovery of 65% of the allowed amount of their general unsecured claims against the collective bankruptcy
estates of the Debtors, without giving effect to Intercompany Claims (the “Other Creditors’ Threshold”).
After such time when the Other Creditors’ Threshold has been so received by such other general unsecured creditors in the
bankruptcy estates of the Debtors (without giving effect to Intercompany Claims), the holder(s) of the DPO Claims shall become
once again entitled to, and shall (to the extent of any available distributions) receive, such distributions on a pro rata
basis (based on allowed DPO Claims in the amount of $30,000,000) with the allowed claims of all other general unsecured creditors
in the bankruptcy estates of the DPO Obligors until the holder(s) of the DPO Claims recover a maximum aggregate amount of $20,000,000
(inclusive of the Initial Recovery Amount and all other amounts received by them in respect of the DPO Claims) (the Initial Recovery
Amount (as modified by the last sentence of this Section 3), plus any amount recovered by the holder(s) of the DPO Claims
in accordance with the terms hereof, being hereinafter referred to as the “Maximum Recoverable Amount”). Notwithstanding
any provision herein or in the Product Purchase Agreement to the contrary, the holder(s) of the DPO Claims hereby irrevocably and
unconditionally waive, effective as of the Effective Date, any right to receive any amount relating to the Deferred Payment Amount
other than, or in excess of, the Maximum Recoverable Amount. The terms and conditions of the foregoing in this Section 3
shall be enforceable against the Released Sellers regardless of whether the Rising Buyer is the Successful Bidder (or is the Back-Up
Bidder and thereafter becomes the Successful Bidder). Only if the Rising Buyer (or any affiliate thereof) is the Successful Bidder
(or is the Back-Up Bidder and thereafter becomes the Successful Bidder), the Initial Recovery Amount shall be reduced by one-half
of the amount, if any, of allowed rejection damage claims in excess of $12,500,000 arising or resulting from Buyer Assumed Agreements
originally set forth on Schedule 1.5 to the Original Rising Purchase Agreement not being assumed by the Rising Buyer and subsequently
rejected by the applicable Rising Seller; provided, that the failure
of the counterparty under any Federal Acquisition Contract or HHS Contract (as each term is defined in the Sale Order (as defined
in the Rising Purchase Agreement)) to permit a novation or substitution of any such contract, and any rejection by the applicable
Seller or rejection damages resulting therefrom, shall not result in a reduction of the Initial Recovery Amount. Notwithstanding
anything to the contrary contained in this Mutual Release, if the Rising Buyer is the Successful Bidder (or is the Back-Up Bidder
and thereafter becomes the Successful Bidder), the entire amount of the Seller Credit and the Deferred Payment Reduction (each
as defined in the Rising Purchase Agreement) shall be applied to the Purchase Price under the Rising Purchase Agreement and shall
not be released hereunder; provided, that for the avoidance of doubt, if the Rising Buyer is not the Successful Bidder (and is
not the Back-up Bidder, or does not become the Successful Bidder), then the amounts reflected in the Seller Credit, any payment
due under the Administration Services Agreement, and any interest in respect of the Deferred Payment amount shall, in each case,
be released, and the Deferred Payment Reduction (in addition to the provisions of this Section 3)shall remain in effect hereunder.

 

    	 	-6-	 

     

    

 

		4.	Miscellaneous.

 

		a.	Representations and Warranties. Each Party hereby represents and warrants to the other Parties
that (i) such Party has had the opportunity to review this Mutual Release with counsel, (ii) such Party has been fully advised
as to the terms herein and fully appreciates and understands such terms, (iii) such Party has all requisite power and authority
to execute and deliver this and to perform his, her or its obligations hereunder, except, with respect to the Parent Parties, such
power and authority is subject to approval of the Bankruptcy Court by Final Order (as defined in the Rising Purchase Agreement),
and (iv) this Mutual Release has been duly and validly executed and delivered by such Party and, assuming the valid execution and
delivery by the other Parties, constitutes a valid and binding agreement of such Party enforceable against such Party in accordance
with its terms, except as the same may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws now or
hereafter in effect relating to creditors’ rights generally and subject to general principles of equity (except, with respect
to the Parent Parties, subject to approval of the Bankruptcy Court by Final Order (as defined in the Rising Purchase Agreement).

 

		b.	No Admission of Liability. The execution of this Mutual Release and the fulfillment of its
terms is a compromise of disputed claims and is not to be construed as, and does not constitute, an admission of liability or wrongdoing
or responsibility on the part of any Party, and the material purpose of the actions taken hereunder are solely for the purpose
of avoiding the expense and time of litigation.

 

		c.	Amendment. No provision or term hereof may be amended, supplemented, or otherwise modified
except by an instrument in writing, specifying the same, duly executed by each of the Parties.

 

		d.	Assigns. The Parties shall not assign any rights or obligations hereunder without the written
consent of all other Parties.

 

		e.	Heading References. The heading references herein are for convenience purposes only, do
not constitute a part of this Mutual Release, and shall not be deemed to limit or affect any of the provisions hereof.

 

		f.	Severability. Should any portion of this Mutual Release be held invalid by operation of
law or by a court with proper jurisdiction, the remaining portion of this Mutual Release shall be given full force and effect and
shall not in any way be affected thereby.

 

		g.	Entire Agreement. This Mutual Release, the Rising Purchase Agreement and the Transaction
Agreements represent the entire understanding and agreement among the Parties with respect to the subject matter hereof, and supersede
all prior agreements, if any, among them with respect thereto. In the event of any conflict or inconsistency between the provisions
of this Mutual Release and the provisions of the Product Purchase Agreement, the provisions of this Mutual Release shall control.

 

		h.	Counterparts. This Mutual Release may be executed in one or more counterparts (including
by facsimile or electronic .pdf submission), each of which shall be deemed an original, and all of which shall constitute one and
the same agreement and shall become effective when one or more counterparts have been signed by each of the Parties and delivered
(by telecopy, portable document format (.pdf) or otherwise) to the other Parties, it being understood that all Parties need not
sign the same counterpart.

 

		i.	Governing Law. This Mutual Release shall be construed and enforced in accordance with the
laws of the State of New York, without regard to any conflict of laws provisions thereof that would result in the application of
the laws of any other jurisdiction.

 

    	 	-7-	 

     

    

 

		j.	Submission to Jurisdiction. Each Party hereto hereby irrevocably and unconditionally: (i)
consents and submits for itself and its property in any Proceeding based upon, arising out of, or related to this Mutual Release
or its negotiation, execution, performance, non-performance, interpretation, termination, construction or the transactions contemplated
hereby, or for recognition and enforcement of any judgment in respect thereof, to the exclusive jurisdiction of the Bankruptcy
Court; (ii) consents that any such Proceeding may be brought in such court, and waives any objection that it may now or hereafter
have to the venue of any such Proceeding in any such court or that such Proceeding was brought in an inconvenient court and agrees
not to plead or claim the same; (iii) agrees that service of process in any such Proceeding may be effected by mailing a copy thereof
by registered or certified mail (or any substantially similar form of mail), postage prepaid, to any Party at its, his or her address
set forth in Section 4.o of this Mutual Release; and (iv) agrees that nothing herein shall affect the right to effect service
of process in any other manner permitted by Law. Each of the Parties also agrees that any final, non-appealable judgment against
a Party in connection with any Proceeding arising out of or relating to this Mutual Release may be enforced in any court of competent
jurisdiction, either within or outside of the United States.

 

		k.	WAIVER OF JURY TRIAL: TO THE FULLEST EXTENT PERMITTED BY LAW, THE PARTIES HEREBY WAIVE THEIR
RESPECTIVE RIGHTS TO A JURY TRIAL OF ANY PROCEEDING BASED UPON, ARISING OUT OF, OR RELATED TO THIS MUTUAL RELEASE, OR ANY OF THE
TRANSACTIONS CONTEMPLATED BY THIS MUTUAL RELEASE. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES
THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS MUTUAL RELEASE, INCLUDING CONTRACT CLAIMS, TORT CLAIMS,
BREACH OF DUTY CLAIMS AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THE PARTIES ACKNOWLEDGE THAT THIS WAIVER IS A MATERIAL INDUCEMENT
TO ENTER INTO A BUSINESS RELATIONSHIP, THAT EACH HAS ALREADY RELIED ON THIS WAIVER IN ENTERING INTO THIS MUTUAL RELEASE AND THAT
EACH WILL CONTINUE TO RELY ON THE WAIVER IN THEIR RELATED FUTURE DEALINGS. THE PARTIES FURTHER WARRANT AND REPRESENT THAT EACH
HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT EACH KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING
CONSULTATION WITH LEGAL COUNSEL. THIS WAIVER IS IRREVOCABLE, MEANING THAT IT MAY NOT BE MODIFIED EITHER ORALLY OR IN WRITING, AND
THIS WAIVER SHALL APPLY TO ANY SUBSEQUENT AMENDMENTS, RENEWALS, SUPPLEMENTS OR MODIFICATIONS TO THIS MUTUAL RELEASE OR TO ANY OTHER
DOCUMENTS OR AGREEMENTS RELATING TO THE TRANSACTIONS CONTEMPLATED HEREBY. IN THE EVENT OF LITIGATION, THIS MUTUAL RELEASE MAY BE
FILED AS A WRITTEN CONSENT TO A TRIAL BY THE COURT.

 

    	 	-8-	 

     

    

 

		l.	Waiver. Any provision hereof may be waived only by written instrument making specific reference
to this Mutual Release signed by the Party against whom enforcement of any such waiver is sought. The waiver by any Party hereto
of a breach of any provision of this Mutual Release shall not operate or be construed as a further or continuing waiver of such
breach or as a waiver of any other or subsequent breach. No failure on the part of any Party to exercise, and no delay in exercising,
any right, power or remedy hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of such right,
power or remedy by such Party preclude any other or further exercise thereof or the exercise of any other right, power or remedy.

 

		m.	Interpretation. Whenever the words “include”, “includes” or “including”
are used in this Mutual Release, they shall be deemed to be followed by the words “without limitation.” References
to sections are to sections in this Mutual Release and in each case include references to all subsections under the referenced
section. The words “hereof,” “herein” and “hereunder” and words of similar import shall refer
to all applicable provisions of this Mutual Release and not to any particular provision. This Mutual Release is the result of negotiation
and, accordingly, no presumption or burden of proof will arise with respect to any ambiguity or question of intent concerning this
Mutual Release favoring or disfavoring any Party by virtue of the authorship of any provision of this Mutual Release. Words denoting
the singular tense or person shall include the plural and vice versa and references to the masculine gender shall, where the context
permits, include the feminine and/or neuter genders and vice versa.

 

		n.	Third Party Beneficiaries. Except for the Released Parent Parties and the Released Seller
Parties, who are not signatories hereto, each of whom shall be an express intended third party beneficiary hereof and be entitled
to enforce this Mutual Release, including to seek an injunction or an order of specific performance, there are no third party beneficiaries,
express or implied, of this Mutual Release.

 

		o.	Notices. All notices or other communications hereunder shall be deemed to have been duly
given and effective upon delivery if in writing and if served by personal delivery upon the Party for whom it is intended, if delivered
by registered or certified mail, return receipt requested, or by a national courier service, or if sent by facsimile or electronic
mail; provided, that the facsimile or electronic mail is promptly confirmed by telephone confirmation thereof or followed
by one of the other foregoing permitted means of notice (other than facsimile or electronic mail), to the Person at the address
set forth below, or such other address as may be designated in writing hereafter, in the same manner, by such Person:

 

    	 	-9-	 

     

    

 

If to any Parent Party:

 

Aceto Corporation

4 Tri Harbor Ct.

Port Washington, NY 11050

Attn: Steven S. Rogers, Chief
Legal Officer

Facsimile No.: (516) 478-9857

Email: srogers@aceto.com

 

with a copy to:

 

Lowenstein Sandler LLP

1251 Avenue of the Americas

New York, NY 10020

Attn: Steven E. Siesser, Esq.

Facsimile No.: (973) 597-2507

Email: ssiesser@lowenstein.com

 

If to any Released Seller:

 

Vimal Kavuru, Agent

[  ]

 

with a copy to (which shall not
constitute notice):

 

Reed Smith LLP

599 Lexington Avenue

Attention: Niket Rele, Esq.

E-mail: nrele@reedsmith.com

 

[Remainder of page intentionally left
blank. Signatures follow.]

 

    	 	-10-	 

     

    

 

IN WITNESS WHEREOF,
each of the undersigned has executed this Mutual Release effective as of the Effective Date.

 

	ACETO CORPORATION 	 
	 	 
	By:	/s/ William C. Kennally, III	 
	 	Name: William C. Kennally, III	 
	 	Title: Chief Executive Officer and President	 

 

	RISING PHARMACEUTICALS, INC. 	 
	 	 
	By:	/s/ William C. Kennally, III	 
	 	Name: William C. Kennally, III	 
	 	Title: Chief Executive Officer	 

 

	ACETRIS HEALTH, LLC	 
	 	 
	By:	/s/ William C. Kennally, III	 
	 	Name: William C. Kennally, III	 
	 	Title: Chief Executive Officer	 

 

	RISING HEALTH, LLC	 
	 	 
	By:	/s/ William C. Kennally, III	 
	 	Name: William C. Kennally, III	 
	 	Title: Chief Executive Officer	 

 

	ACETO AGRICULTURAL CHEMICALS CORPORATION	 
	 	 
	By:	/s/ William C. Kennally, III	 
	 	Name: William C. Kennally, III	 
	 	Title: Authorized Signatory	 

 

[Signature page to Amended and Restated
Mutual Release]

 

     

     

    

 

	ACETO REALTY LLC	 
	 	 
	By:	/s/ William C. Kennally, III	 
	 	Name: William C. Kennally, III	 
	 	Title: Chief Executive Officer	 

 

	PACK PHARMACEUTICALS, LLC	 
	 	 
	By:	/s/ William C. Kennally, III	 
	 	Name: William C. Kennally, III	 
	 	Title: Chief Executive Officer	 

 

	ARSYNCO, INC.	 
	 	 
	By:	/s/ William C. Kennally, III	 
	 	Name: William C. Kennally, III	 
	 	Title: Chief Executive Officer	 

 

	ACCI REALTY CORP.	 
	 	 
	By:	/s/ William C. Kennally, III	 
	 	Name: William C. Kennally, III	 
	 	Title: Chief Executive Officer	 

 

[Signature page to Amended and Restated
Mutual Release]

 

     

     

    

 

	sHORE PHARMA LLC	 
	 	 
	By:	/s/ Vimal Kavuru	 
	 	Name: Vimal Kavuru	 
	 	Title: Sole Member	 

 

	Cedar Pharma LLC	 
	 	 
	By:	/s/ Vimal Kavuru	 
	 	Name: Vimal Kavuru	 
	 	Title: Manager and CEO	 

 

	Aster pharma LLC	 
	 	 
	By:	/s/ Vimal Kavuru	 
	 	Name: Vimal Kavuru	 
	 	Title: Manager and CEO	 

 

	CITGEN PHARMA HOLDING LLC	 
	 	 
	By:	/s/ Vimal Kavuru	 
	 	Name: Vimal Kavuru	 
	 	Title: Manager	 

 

	GENSOURCE PHARMA LLC	 
	 	 
	By:	/s/ Vimal Kavuru	 
	 	Name: Vimal Kavuru	 
	 	Title: Manager	 

 

	SS PHARMA LLC	 
	 	 
	By:	/s/ Subha Sri Thogarchedu	 
	 	Name: Subha Sri Thogarchedu	 
	 	Title: Sole Member	 

 

[Signature page to Amended and Restated
Mutual Release]

 

     

     

    

 

	PHARMA REACH LLC	 
	 	 
	By:	/s/ Subha Sri Thogarchedu	 
	 	Name: Subha Sri Thogarchedu	 
	 	Title: Sole Member	 

 

	CITGEN REALTY LLC	 
	 	 
	By:	/s/ Vimal Kavuru	 
	 	Name: Vimal Kavuru	 
	 	Title: Manager	 

 

	/s/ Sudha Kavuru	 
	Sudha Kavuru, individually	 
	 	 
	/s/ Vimal Kavuru	 
	Vimal Kavuru, individually and as Agent	 
	 	 
	/s/ Subha Sri Thogarchedu	 
	Subha Sri Thogarchedu, individually	 

 

[Signature page to Amended and Restated
Mutual Release]Exhibit 10.1

      

      

      March 27, 2019

      

      

      Mr. James Pollock

      1421 Frog Hollow Road

      Rydal, PA  19046

      

      

      Dear Jim:

      

      

      We are pleased to extend to you an offer of employment to join USA Technologies, Inc. (“USA”) as Chief Compliance Officer. In your role as Chief Compliance
          Officer you will report to the Compliance Committee of USA’s Board of Directors. Your first day of employment will be April 15, 2019.

      

      

      This offer is contingent upon approval of this letter by our Board of Directors which is expected to be no later than March 22, 2019.

      

      

      The following are the terms of your employment:

      

      

      
        
          	

                	·	
                  Your annual base salary will be $235,000.

                

        

      

      
        
          	

                	·	
                  Signing bonus of incentive stock options to purchase up to 20,000 shares exercisable at the closing price of the shares on the date of grant. The options would vest over
                      a three-year period as follows, provided that you are employed by USA on the respective vesting dates:  one-third on the first annual anniversary of the date of the grant; one-third on the second annual anniversary of the date of the
                      grant; and one-third on the third annual anniversary of the date of the grant. The options would be exercisable for a period of seven years from the grant date. The
                      options would not be exercisable in any event unless or until USA would be eligible to utilize a Form S-8 registration statement under the Securities Act of 1933.

                

        

      

      
        
          	

                	·	
                  An additional signing bonus consisting of a cash payment of $30,000 to be paid on August 15, 2019, provided you are employed by USA on such date. The payment shall be
                      subject to customary payroll and tax withholdings and deductions.

                

        

      

      
        
          	

                	·	
                  You will participate in a Short-Term Incentive Plan. If the target goals would be achieved, you would earn a cash bonus equal to 30% of your base salary. For fiscal year
                      2019, your STI award would be pro-rated from your start date through the end of USA’s fiscal year ended June 30, 2019. Your target goals under the fiscal year 2019 plan would be formalized by the Compensation Committee promptly
                      following the date hereof, and would be based solely upon achievement of the compliance plan that you had previously prepared.

                

           

          

        

      

      
        
          

      

      
        Offer of Employment

        James Pollock

        Page 2

         

            

      

      
        
          	

                	·	
                  You will participate in a Long-Term Incentive Stock Plan. If each of the target goals would be achieved, you would earn an equity award with a value on the last day of
                      the applicable fiscal year equal to 20% of your base salary. For fiscal year 2019, your LTI award would be pro-rated from your start date through the end of USA’s fiscal year ended June 30, 2019.  If each of the target goals would be
                      achieved for the fiscal year 2019 plan, you would earn (subject to proration) an award of incentive stock options to purchase up to 30,000 shares with an exercise price equal to the closing price of the shares on June 30, 2019. The
                      options  would vest over a three-year period as follows, provided that you are employed by USA on the respective vesting dates:  one-third at the time of issuance; one-third on June 30, 2020; and one-third on June 30, 2021. The
                      options would be exercisable for a period of seven years from the grant date. Your target goals under the plan would be the same as for the other executive officers and would be based upon the actual performance of USA. The options
                      would not be exercisable in any event unless or until USA would be eligible to utilize a Form S-8 registration statement under the Securities Act of 1933.

                

        

      

      
        
          	

                	·	
                  The Compensation Committee  of USA’s Board of Directors, in consultation with the Compliance Committee, shall annually review your compensation.

                

        

      

      
        
          	

                	·	
                  You would be covered by and entitled to all of the fringe benefits that are generally available to USA employees, including health insurance, dental insurance, group life
                      and disability insurance, and matching 401(k) plan. Please note that USA’s benefits program is subject to change and any such change would supersede this letter.

                

        

      

      
        
          	

                	·	
                  You will be covered as an executive officer of USA under our Directors and Officers liability insurance policy.

                

        

      

      
        
          	

                	·	
                  Employment with USAT is at-will, which means that either you or USA may end the relationship at any time for any or no reason. Notwithstanding the foregoing, and  other
                      than a termination of your employment for cause (which shall not require any prior notice), USA will provide you with at least six (6) months prior notice of the termination of your employment for any or no reason. The term "cause"
                      shall mean any of the following have occurred or exist as determined by USA: (A) your fraud, gross malfeasance, or willful misconduct, with respect to USA's business; (B) any material breach by you of this letter or any policy of USA;
                      (C) any violation by you of any law, rule or regulation, which violation results or could reasonably be expected to result, in material harm to the business or reputation of USA; (D) conviction of or the entry of a guilty plea or plea
                      of no contest to any felony or to any other crime involving moral turpitude; or (E) any intentional misapplication by you of USA's funds, or any material act of dishonesty committed by you.

                

        

      

      
        
          	

                	·	
                  You will devote your full time, energy, skills and attention to the business of USA, and shall not be engaged or employed in any other business activity whatsoever,
                      whether or not such activity is pursued for gain, profit or other pecuniary advantage.

                

           

          

        

      

      
        
          

      

      
        
          
            Offer of Employment

            James Pollock

            Page 3

          

           

          

          	

                	·	
                  Except in connection with your duties as Chief Compliance Officer, you shall not, directly or indirectly, at any time from and after the date hereof, and whether or not
                      your employment with USA has been terminated or has expired for any reason whatsoever, make any use of, exploit, disclose, or divulge to any other person, firm, or corporation, any confidential information, including but not limited
                      to, proprietary information, trade secret, business secret, financial information, financial projections, documents, process, procedures, know-how, data, marketing information, marketing method, marketing means, software information,
                      intellectual property, special arrangement, or any other confidential information concerning the business or policies of USA, or concerning USA' s customers, clients, accounts, or suppliers, that you learned as a result of, in
                      connection with, through your engagement with, or through your affiliation with USA, but not information that can be shown through documentary evidence to be in the public domain, or information that falls into the public domain,
                      unless such information falls into the public domain by your direct or indirect disclosure or other acts. You agree to use your best endeavors to prevent the unauthorized disclosure or publication of confidential information and not
                      to copy nor remove confidential information from USA’s premises, whether physically or electronically, without the express written permission of USA.

                

        

      

      
        
          	

                	·	
                  You acknowledge that you will be subject to the following policies of USA: Employee Manual, Code of Business Conduct and Ethics, as amended; Blackout Period and
                      Notification Policy; and Stock Ownership Guidelines for Directors and Executive Officers as well as any other policies that may be adopted by USA from time to time. As Chief Compliance Officer, you would also be required to file
                      statements of beneficial ownership of USA securities pursuant to Section 16(a) of the Securities Exchange Act of 1934.

                

        

      

      
        
          	

                	·	
                  You represent and warrant to USA that you are not as of the date of this letter a party to or subject to any employment, non-compete, or similar agreement that would
                      limit or prohibit, in whole of in part, the performance of your employment duties or responsibilities.

                

        

      

      

      

      This letter constitutes our entire agreement and understanding regarding the matters addressed herein, and merges and supersedes all prior or
          contemporaneous discussions, agreements and understandings of every nature between us regarding these matters.

      

      

      This letter will be governed by, and enforced in accordance with, the laws of the Commonwealth of Pennsylvania, without regard to the application of the
          principles of conflicts of laws.

       

        

       Your employment with USA will also be subject to a satisfactory background investigation to be conducted by USA.

       

        

      
        
          

      

      
        Offer of Employment
          James Pollock

          Page 4

        

         

          

        Jim, we are very much looking forward to your joining the USA team! Please indicate your written acceptance by signing this letter and returning it to me
            by email.

        

        

        Sincerely,

        

        

        	
                USA Technologies, Inc.

              	 

        

        

        	
                By:

              	
                /s/ Stephen P. Herbert

              
	
                Stephen P. Herbert, Chief Executive Officer

              

        

        

        	
                Accepted and Agreed to:

              	 
	 	 
	
                /s/ James Pollock

              	 
	
                James Pollock

              	 
	 	 
	
                Dated:  3/27/2019

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00294-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00294-of-00352.parquet"}]]